Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.
Classification of human immunodeficiency virus type 1 (HIV-1) by neutralization serotype may be important for the design of active and passive immunization strategies. Neutralizing antibody serotyping is hindered by the lack of standard reagents and assay format, and by the weak activity of many individual sera. To facilitate cross-clade neutralization analysis, we used an infectivity reduction assay (IRA) and selected clade-specific serum (or plasma) pools from subjects infected with clade B and E HIV-1, respectively. Several serum pools were utilized; some were selected for strong neutralizing activity against intraclade viruses and others were derived from conveniently available samples. Against a panel of 51 clade B and E viruses, serum pools displayed strong neutralization of most intraclade viruses and significantly diminished cross-clade neutralization. Results were confirmed against a blinded panel of 20 viruses. The data indicate that the phylogenetic classification of virus subtypes B and E corresponds to two distinct neutralization serotypes. This approach to neutralizing antibody serotyping may be useful in defining the antigenic relationship among viruses from other clades.
Mascola
J R
JR
Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland 20850, USA.
Louder
M K
MK
Surman
S R
SR
Vancott
T C
TC
Yu
X F
XF
Bradac
J
J
Porter
K R
KR
Nelson
K E
KE
Girard
M
M
McNeil
J G
JG
McCutchan
F E
FE
Birx
D L
DL
Burke
D S
DS
D004797:Enzyme-Linked Immunosorbent Assay; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D019302:HIV Envelope Protein gp160 / Q000378:metabolism; D006679:HIV Seropositivity / Q000175:diagnosis*; D006801:Humans; D009500:Neutralization Tests; D010446:Peptide Fragments / Q000378:metabolism; D012703:Serotyping / Q000379:methods*
D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments